FemTech Insight Digest

Sustained VC momentum in women's health:

• 2024 funding hit $2.6B, up 55% YoY
• Go Red for Women fund targets $75M, among world's largest for women's...

• Diagnostics overlooked globally, slowing precision health despite therapy advances
• Nearly half the world's population lacks access; tests get less...

Groundbreaking Nature Medicine study maps 198 proteins fluctuating across cycle phases, confirming impacts on mood, digestion, energy.

• Whole-body...

Regulatory milestone for non-hormonal menopause therapies:

• FDA "Study May Proceed" letter enables phase 2 under IND for refisolone nasal spray...

Key validation of neuroproliferative dyspareunia in endometriosis from 180-patient registry:

• PGP9.5 nerve density around posterior lesions...

Myth busted: Social media claims of 18–24% body fat for optimal health in women 40s–50s rely on a flawed 2012 study of BMI<25 adults, not...

Premature Menopause and CHD Risk

• 🔥 40% Higher Lifetime Risk: A new study published in JAMA Cardiology links premature menopause before age 40...

JAMA Cardiology study of ~10,000 women shows premature menopause (before 40) ties to 40% higher lifetime coronary heart disease risk.

• Racial gap:...

Key diagnostic breakthrough from HerAnova Lifesciences:

• 80% sensitivity, 97.5% specificity in 298-patient study (177 confirmed cases)
• Detects...

Emerging research spotlights FemTech diagnostics/therapy potential:

• Vulvodynia subtypes: Hormonally-driven cases show 70% response to...

FemTech Funding Rounds

• 🔥 Diamens Pre-Seed: Austrian startup Diamens raised a six-figure pre-seed round to develop and clinically validate a...

Key practical strategies from Dr. Wynne for family physicians:

• Screening essentials: Use Mini-Cog during Medicare wellness visits or caregiver...

Rising trend in menopause integration reveals support gaps:

• Health system hubs now open across all Welsh health boards, localizing menopause care
  -...

Malama Health secured $9.2 million in seed funding to scale its doula-led maternal care platform for Medicaid-insured women. This underscores investor backing for reimbursement-relevant innovations serving underserved maternal health segments.

Key developments signaling faster, scalable diagnostics:

• Austrian startup Diamens raises six-figure pre-seed to advance menstrual blood-based...

Hologic Index reveals persistent global gaps despite modest screening upticks, spotlighting urgent need for diagnostic FemTech in under-screened...

• Patient odyssey: 33yo endured 20-year diagnostic delay from puberty pain, gaslighting, masked symptoms via birth control, to 23-lesion surgery.
  -...

Fund That Tiger launches with $10M target for Clemson alumni-led startups, offering a blueprint for university-affinity funds in emerging markets.

-...

Compliance algorithms systematically label women’s health startups—from fertility apps to sexual wellness brands—as high-risk, creating a global financial blockade. This underscores systemic barriers as a key non-dilutive funding risk for FemTech.

Exits & Non-Dilutive Funding

• 🔥 Venture Catalysts 9.6x Exit from Pee Safe: Early-stage investor Venture Catalysts exited women’s hygiene startup...